Ceribell, Inc. (CBLL) stock: key figures, P/E, revenue and dividend
Health Care · United States · ISIN US15678C1027
Ceribell, Inc. financials
| Fiscal year | 2025 |
|---|---|
| Revenue | 89.06 m USD |
| Gross profit | 78.27 m USD |
| Operating income | -58.40 m USD |
| EBIT | -51.52 m USD |
| Net income | -53.41 m USD |
| Diluted EPS – continuing operations | -1.46 USD |
Full history since 2022, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Ceribell, Inc.
CeriBell, Inc. operates as a medical technology company in the United States. It develops the Ceribell System, a novel and point-of-care EEG platform specifically designed to address the unmet needs of patients in the acute care setting. The company also offers disposable, flexible headbands, and headcaps; and a pocket-sized, rechargeable battery-operated recorder used to capture and wirelessly transmit EEG signals; and Clarity, an AI-powered seizure detection algorithm. In addition, it operates an EEG portal, which enables real-time remote access to a patient's EEG data. The company was formerly known as Brain Stethoscope, Inc. and changed its name to CeriBell, Inc. in August 2015. CeriBell, Inc. was incorporated in 2014 and is headquartered in Sunnyvale, California.
More stocks
- EAGLE BANCORP INC (EGBN)
- Zhejiang Sanwei Rubber Item Co (603033.SS)
- HARROW, INC. (HROW)
- Renta 4 Banco SA (R4.MC)
- KFORCE INC (KFRC)
- Fugro NV (FUR.AS)
- Bio-Thera Solutions Ltd (688177.SS)
- Power HF Co Ltd (605100.SS)
- Three Squirrels (300783.SZ)
- PT Daya Intiguna Yasa Tbk (MDIY.JK)
- ShenZhen Kondarl Group Co Ltd (000048.SZ)
- Maschinenfabrik Berthold Hermle (MBH3.F)
Not investment advice. All data without warranty, price as of 29.10.2026. Details in the risk notice.